Pfizer Recalls Relpax Tablets Due to Microbial Contamination
Pfizer is recalling specific lots of Relpax (eletriptan HBr) tablets because they may be contaminated with Burkholderia and Pseudomonas bacteria.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves microbial contamination with Burkholderia and Pseudomonas, which are high-risk pathogens that can cause serious health issues, fitting the criteria for a Severe rating.
Plain-English summary
Pfizer Inc. is recalling specific lots of Relpax (eletriptan HBr) tablets, 40 mg, due to microbial contamination. The affected products are packaged in 6-count and 12-count cartons and were distributed nationwide in the USA and Puerto Rico.
The recall is being conducted because the tablets may be contaminated with Burkholderia and Pseudomonas bacteria. The specific lots involved are AR5407 and CD4565, both with an expiration date of February 2022. The agency has classified this recall as Class II.
Consumers and healthcare providers should check their inventory for these specific lot numbers and stop using the affected tablets. They should contact their pharmacist or healthcare provider for guidance on replacement or further instructions.
The recalled product
- Product
- RELPAX (eletriptan HBr) tablets, 40 mg, packaged in a) 6-count (1 card x 6 tablets) per carton, NDC 0049-2340-45; b) 12-count (2 cards x 6 tablets) per carton, NDC 0049-2340-05, Rx only, Made in Ireland, Distributed by Pfizer Roerig, Division of Pfizer Inc., NY, NY 10017.
- Manufacturer
- Pfizer Inc.
- Category
- Drug — Prescription Medication
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot #: a) AR5407
- Exp 2022 FEB
- b) CD4565
Distribution
Related recalls
Same manufacturer · Pfizer Inc.
See all →- HighSodium bicarbonate injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighEpinephrine injection vials recalled for lack of assurance of sterility
FDA (Drugs) · 2025-08-27
- HighBicillin L-A penicillin vials recalled after particulates found during visual inspection
FDA (Drugs) · 2025-08-06
- HighBicillin L-A 2.4 million unit vials recalled after particulates found
FDA (Drugs) · 2025-08-06
- ModerateDobutamine Injection Recall Due to Discoloration and Cracked Vials
FDA (Drugs) · 2025-07-02
Same hazard · microbial contamination
See all →- CriticalVictory Medical Center Pharmacy Recalls Glutathione Vials Due to Contamination
FDA (Drugs) · 2026-08-19
- HighMedline Medical Convenience Kits Recalled Due to Potential Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighMedline Convenience Kits Recalled Over Bacillus Contamination
FDA (Devices) · 2026-07-29
- HighROHTO Cooling Eye Drops Recalled Over Sterility Assurance Concerns
FDA (Drugs) · 2026-07-29
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15